Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies
Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies
复制标题
DOI：
10.1016/j.sapharm.2020.05.017
复制
发表时间：
2021-01-01
影响因子：
3.9
通讯作者：
Atallah, Bassam
中科院分区：
文献类型：
--
作者：
Badreldin, Hisham A.;Atallah, Bassam
2019冠状病毒病（COVID-19）源自中国武汉，目前正在全球范围内爆发。世界卫生组织（WHO）已宣布COVID-19为全球大流行病。COVID-19可能引起广泛的症状，从自限性发热、喉咙痛和咳嗽到可能导致急性呼吸窘迫综合征的更严重症状。由于封锁和需求增加，药物短缺可能成为一个日益严重的全球问题。本文旨在阐明由于这种流行病对患者结局造成的药物短缺的潜在影响，以及药剂师和药房政策制定者在缓解这一新出现的问题方面的作用。
Coronavirus disease 2019 (COVID-19) arising from Wuhan, China, is currently outbreaking worldwide. The World Health Organization (WHO) has declared COVID-19 to be a global pandemic. COVID-19 could cause a wide range of symptoms ranging from self-limiting fever, sore throat, and cough to more severe symptoms that could lead to acute respiratory distress syndrome. As a result of the lockdown and increased demand, drug shortages could become a growing global issue. This article aims to shed light on the potential impact of drug shortages as a result of this pandemic on patient outcomes and the role of pharmacists and pharmacy policy makers in alleviating this emerging problem.